Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older Adults
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Recent studies have suggested an increased fracture risk with acid-suppressive medication use. We studied two cohorts of men and women over age 65 who were enrolled in the Osteoporotic Fractures in Men Study (MrOS) and the Study of Osteoporotic Fractures (SOF), respectively. We used dual-energy X-ray absorptiometry and assessed baseline use of proton pump inhibitors (PPIs) and/or H2 receptor antagonists (H2RAs) in 5,755 men and 5,339 women. Medication use and bone mineral density (BMD) were assessed, and hip and other nonspine fractures were documented. On multivariate analysis, men using either PPIs or H2RAs had lower cross-sectional bone mass. No significant BMD differences were observed among women. However, there was an increased risk of nonspine fracture among women using PPIs (relative hazard [RH] = 1.34, 95% confidence interval [CI] 1.10–1.64). PPI use was also associated with an increased risk of nonspine fracture in men but only among those who were not taking calcium supplements (RH = 1.49, 95% CI 1.04–2.14). H2RA use was not associated with nonspine fractures, and neither H2RA use nor PPI use was associated with incident hip fractures in men or women. The use of PPIs in older women, and perhaps older men with low calcium intake, may be associated with a modestly increased risk of nonspine fracture.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schafer, J. L. (1999) · Statistical Methods in Medical Research · doi:10.1177/096228029900800102 · Cited by 3,949
Cited by
Gray, S. L. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.94 · Cited by 329
Ito, T., & Jensen, R. T. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0141-0 · Cited by 309
Adverse Effects of Long-Term Proton Pump Inhibitor Therapy
Sheen, E., & Triadafilopoulos, G. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1560-3 · Cited by 307
Proton Pump Inhibitors and Risk of Fractures: A Meta-Analysis of 11 International Studies
Yu, E. W., Bauer, S. R., Bain, P. A., & Bauer, D. C. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.01.007 · Cited by 295
Self-citationNgamruengphong, S., Leontiadis, G. I., Radhi, S., Dentino, A., & Nugent, K. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.113 · Cited by 281
Corley, D. A., Kubo, A., Zhao, W., & Quesenberry, C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.055 · Cited by 271
Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
Kinoshita, Y., Ishimura, N., & Ishihara, S. (2018) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm18001 · Cited by 271
Targownik, L. E., Lix, L. M., Leung, S., & Leslie, W. D. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.11.014 · Cited by 253
Proton-pump inhibitors and risk of fractures: an update meta-analysis
Zhou, B., Huang, Y., Li, H., Sun, W., & Liu, J. (2016) · Osteoporosis International · doi:10.1007/s00198-015-3365-x · Cited by 252
“They were published between 2006 and 2014 including nine case-control studies [16–18, 21, 23, 24, 27, 29, 32] and nine prospective studies [19, 20, 22, 25, 26, 28, 30, 31].”
Seto, C. T., Jeraldo, P., Orenstein, R., Chia, N., & DiBaise, J. K. (2014) · Microbiome · doi:10.1186/2049-2618-2-42 · Cited by 163
“Specifically, their prolonged use has been associated with iron [4] and vitamin B12 [5,6] deficiencies, hypomagnesemia [7], osteoporosis-related fractures [8,9], small intestinal bacterial overgrowth [10,11], and community-acquired pneumonia [12,13].”
BackgroundPerils and pitfalls of long-term effects of proton pump inhibitors
Wilhelm, S. M., Rjater, R. G., & Kale-Pradhan, P. B. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2013.811206 · Cited by 104
Adverse outcomes of long-term use of proton pump inhibitors: a systematic review and meta-analysis
Islam, M. M., Poly, T. N., Walther, B. A., Dubey, N. K., Anggraini Ningrum, D. N., Shabbir, S.-A., & (Jack) Li, Y.-C. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001198 · Cited by 88
de la Coba Ortiz, C., Argüelles Arias, F., Martín de Argila de Prados, C., Júdez Gutiérrez, J., Linares Rodríguez, A., Ortega Alonso, A., Rodríguez de Santiago, E., Rodríguez-Téllez, M., Vera Mendoza, M. I., Aguilera Castro, L., et al. (2016) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2016.4232/2016 · Cited by 54
Metadata
- Authors
- Yu, E. W., Blackwell, T., Ensrud, K. E., Hillier, T. A., Lane, N. E., Orwoll, E., & Bauer, D. C.
- Venue
- Calcified Tissue International
- Published
- 2008-09-24
- Volume
- 83
- Issue
- 4
- Pages
- 251-259
- ISSN
- 0171-967X (ISSN-L)
- 1432-0827
- OpenAlex
- W2082010609
- Cited by
- 210
- References
- 1
- FWCI
- 13.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.